Advertisement
Joining Mr. Weibing Lu, Chairman and Chief Executive Officer of Skystar,will be Ms. Erna Gao, Chief Financial Officer, Mr. Scott Cramer, Director andU.S. representative, and Mr. Wei Wen, Secretary and Director. The Companyplans to make its earnings announcement earlier that same day.
Advertisement
To participate in the live conference call, please dial the followingnumber five to ten minutes prior to the scheduled conference call time: 866-202-3048. International callers should dial 617-213-8843. When prompted by theoperator, mention Conference Passcode 60925366.
If you are unable to participate in the call at this time, a replay willbe available for seven days starting on Wednesday, August 15 at 12:00 p.m.Eastern Time. To access the replay, dial 888-286-8010 and enter the passcode14701349. International callers should dial 617-801-6888 and enter the samepasscode 14701349.
In addition, the conference will be broadcast live over the Internet andcan be accessed by all interested parties athttp://phx.corporate-ir.net/playerlink.zhtml?c=197014&s=wm&e=1624298 . Tolisten to the call please go to the website at least 15 minutes prior to thestart of the call to register, download and install any necessary audiosoftware.
About Skystar Bio-Pharmaceutical
Skystar Bio-Pharmaceutical Company is a China-based producer anddistributor of vaccines, microorganisms and veterinary medication to cure andprevent disease in poultry, livestock, birds and pets. The company's productline consists of more than 100 products with over 50 additional products inthe developmental stage. Skystar has formed strategic sales distributionnetworks throughout China. The company recently completed the first phase ofconstruction of new state-of-the-art bio-pharmaceutical facilities covering anarea of almost eight acres. The new facilities meet or exceed all GoodManufacturing Practice (GMP) Certification Standards and have received GMPCertification from the Chinese government. For additional information, pleasevisit http://www.skystarbio-pharmaceutical.com .
Safe Harbor Statement
This announcement may contain "forward-looking statements" within themeaning of the safe harbor provisions of the Private Securities LitigationReform Act of 1995. All statements other than statements of historical fact inthis announcement are forward-looking statements, including but not limited to,statements regarding the Company's plans for future operations. These forward-looking statements involve known and unknown risks and uncertainties and arebased on current expectations, assumptions, estimates and projections aboutthe Company and the industry. Although the Company believes that theexpectations expressed in these forward looking statements are reasonable,they cannot assure you that their expectations will turn out to be correct,and investors are cautioned that actual results may differ materially from theanticipated results.For more information, please contact: Scott Cramer Director - U.S. Representative Skystar Bio-Pharmaceutical Co., Ltd Tel: +1-407-645-4433 Email: [email protected] CCG Elite Investor Relations Crocker Coulson, President Email: [email protected] Leslie Richardson, Financial Writer CCG Elite Investor Relations Tel: +1-310-231-8600 x122 Email: [email protected]
SOURCE Skystar Bio-Pharmaceutical Co., Ltd.
